The Symposium on “Advanced therapies in Neurodegeneration: Bridging Neuroscience, Bioengineering and Optogenetics” invites scientists for two days (April 29 & 30, 2020) to the beautiful city of Lisbon, Portugal and the Champalimaud Centre for the Unknown to discuss advances in the field of Neurodegenerative Diseases. The conference is organized by the Early Stage Researchers of the Marie Skłodowska-Curie Actions Horizon 2020 project Training4CRM.
The event is free of charge, funded by Horizon 2020, and will feature a lot of interesting talks about Neuroscience, Neurodegenerative diseases like Parkinson's Disease, Huntington's Disease and Epilepsy, Stem Cell Therapy, Bioengineering and Optogenetics. Furthermore, a poster session and social networking aim to create new scientific contacts and collaborations. More information about the symposium can be found here: http://training4crm.com/symposium/
Speakers
Juan Jose Toledo Aral, IBIS Sevilla
Etienne Hirsch, ICM Paris
Anne Rosser, Cardiff University
Selina Wray, University College London
Claudia Cavadas, University of Coimbra
Ernest Arenas, Karolinska Institute Stockholm
A. Cristina Rego, University of Coimbra
Maria Joana Albuquerque Osório, Center for Translational Neuromedicine, Copenhagen
Eduardo Moreno, Champalimaud Foundation Lisbon: Beneficial role of neuronal culling during neurodegeneration
Zaal Kokaia, Lund University
Brian Lau, ICM Paris
Nigel M Hooper, University of Manchester
Darcy Wagner, Lund University
My Anderson, Lund University
Noam Shemesh, Champalimaud Foundation Lisbon
Mercè Masana, University of Barcelona
